Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015. (July 2016)
- Record Type:
- Journal Article
- Title:
- Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015. (July 2016)
- Main Title:
- Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14–15 September 2015
- Authors:
- Williams, David J
Archer, Richard
Archibald, Peter
Bantounas, Ioannis
Baptista, Ricardo
Barker, Roger
Barry, Jacqueline
Bietrix, Florence
Blair, Nicholas
Braybrook, Julian
Campbell, Jonathan
Canham, Maurice
Chandra, Amit
Foldes, Gabor
Gilmanshin, Rudy
Girard, Mathilde
Gorjup, Erwin
Hewitt, Zöe
Hourd, Paul
Hyllner, Johan
Jesson, Helen
Kee, Jasmin
Kerby, Julie
Kotsopoulou, Nina
Kowalski, Stanley
Leidel, Chris
Marshall, Damian
Masi, Louis
McCall, Mark
McCann, Conor
Medcalf, Nicholas
Moore, Harry
Ozawa, Hiroki
Pan, David
Parmar, Malin
Plant, Anne L
Reinwald, Yvonne
Sebastian, Sujith
Stacey, Glyn
Thomas, Robert J
Thomas, Dave
Thurman-Newell, Jamie
Turner, Marc
Vitillo, Loriana
Wall, Ivan
Wilson, Alison
Wolfrum, Jacqueline
Yang, Ying
Zimmerman, Heiko
… (more) - Abstract:
- This paper summarizes the proceedings of a workshop held at Trinity Hall, Cambridge to discuss comparability and includes additional information and references to related information added subsequently to the workshop. Comparability is the need to demonstrate equivalence of product after a process change; a recent publication states that this 'may be difficult for cell-based medicinal products'. Therefore a well-managed change process is required which needs access to good science and regulatory advice and developers are encouraged to seek help early. The workshop shared current thinking and best practice and allowed the definition of key research questions. The intent of this report is to summarize the key issues and the consensus reached on each of these by the expert delegates.
- Is Part Of:
- Regenerative medicine. Volume 11:Number 5(2016)
- Journal:
- Regenerative medicine
- Issue:
- Volume 11:Number 5(2016)
- Issue Display:
- Volume 11, Issue 5 (2016)
- Year:
- 2016
- Volume:
- 11
- Issue:
- 5
- Issue Sort Value:
- 2016-0011-0005-0000
- Page Start:
- 483
- Page End:
- 492
- Publication Date:
- 2016-07
- Subjects:
- advice -- comparability -- human pluripotent stem cell derived -- manufacturing -- quality -- regulatory
Cellular therapy -- Periodicals
Stem cells -- Transplantation -- Periodicals
Degeneration (Pathology) -- Treatment -- Periodicals
Regeneration (Biology) -- Periodicals
611.018 - Journal URLs:
- http://www.futuremedicine.com/loi/rme ↗
http://www.futuremedicine.com/ ↗ - DOI:
- 10.2217/rme-2016-0053 ↗
- Languages:
- English
- ISSNs:
- 1746-0751
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7336.506960
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 21431.xml